Wednesday, January 2, 2019

Millipede Medical Acquired By Boston Scientific

Santa Rosa-based Millipede Medical, which makes transcatheter annuioplasty rings for treating mitral regurgitation, has been acquired by Boston Scientific, in a deal worth $325M, with a possible earnout of $125M more. Boston Scientific was already an investor in Millipede Medical, having invested $90M in the company in January of 2018. Randy Lashinski is co-founder and CEO of Millipede.